Based on the agilon health Inc stock forecast from 8 analysts, the average analyst target price for agilon health Inc is USD 6.06 over the next 12 months. agilon health Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of agilon health Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, agilon health Inc’s stock price was USD 2.52. agilon health Inc’s stock price has changed by -10.64% over the past week, -32.62% over the past month and -86.05% over the last year.
No recent analyst target price found for agilon health Inc
No recent average analyst rating found for agilon health Inc
Company Overview agilon health Inc
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. Address: 6210 East US Highway 290, Austin, TX, United States, 78723 Read Less
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly k...Read More
Frequently Asked Questions About agilon health Inc (AGL) Stock
Based on ratings from 8 analysts agilon health Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, 1 sell and 6 hold ratings.
Unfortunately we do not have enough data on AGL's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for AGL is USD 6.06 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 3.
Unfortunately we do not have enough data on AGL's stock to indicate if its overvalued.
The last closing price of AGL's stock was USD 2.52.
The most recent market capitalization for AGL is USD 1.11B.
Based on targets from 8 analysts, the average taret price for AGL is projected at USD 6.06 over the next 12 months.
This means that AGL's stock price may go up by +140.30% over the next 12 months.
We can't find any ETFs which contains agilon health Inc's stock.
As per our most recent records agilon health Inc has 1,117 Employees.
agilon health Inc's registered address is 6210 East US Highway 290, Austin, TX, United States, 78723.
You can get more information about it from agilon health Inc's website at https://www.agilonhealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About agilon health Inc (AGL) Stock
Based on ratings from 8 analysts agilon health Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, 1 sell and 6 hold ratings.
Unfortunately we do not have enough data on AGL's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for AGL is USD 6.06 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 3.
Unfortunately we do not have enough data on AGL's stock to indicate if its overvalued.
The last closing price of AGL's stock was USD 2.52.
The most recent market capitalization for AGL is USD 1.11B.
Based on targets from 8 analysts, the average taret price for AGL is projected at USD 6.06 over the next 12 months.
This means that AGL's stock price may go up by +140.30% over the next 12 months.
We can't find any ETFs which contains agilon health Inc's stock.
As per our most recent records agilon health Inc has 1,117 Employees.
agilon health Inc's registered address is 6210 East US Highway 290, Austin, TX, United States, 78723.
You can get more information about it from agilon health Inc's website at https://www.agilonhealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AGL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
